Press releases

"Our strong performance in the second quarter reflects the consistent execution of our global teams," said Mike Mahoney, CEO of Boston Scientific.

First guidewire designed specifically for TAVI/R now sized for smaller ventricles

First Patients Enrolled in the FAST Feasibility Study

Chairman Pete Nicholas welcomes James as a business leader with “significant financial knowledge, HR management and organizational planning skills.”

Demonstrates growing clinical acceptance for novel, procedure-based treatment option for severe asthma

Boston Scientific will webcast its conference call with financial results and business highlights for Q2 ending June 15, 2015. Learn how to tune in.

Study to evaluate patients implanted with S-ICD for primary prevention of sudden cardiac death in the setting of severely reduced cardiac function

Spinal cord stimulator (SCS) system provided 1.5x better overall pain relief and 2x better low back pain relief than previous generation system

World's smallest 16-contact high-capacity primary cell device expands spinal cord stimulator system (SCS) offering

Boston Scientific will participate in the healthcare conference on June 9, 2015. Learn how to watch the webcast or replay.